nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—CYP3A7—Simvastatin—atherosclerosis	0.0848	0.118	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0848	0.118	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.083	0.115	CbGbCtD
Zaleplon—CYP3A7—Lovastatin—atherosclerosis	0.083	0.115	CbGbCtD
Zaleplon—CYP3A5—Rosuvastatin—atherosclerosis	0.0684	0.0952	CbGbCtD
Zaleplon—CYP3A5—Simvastatin—atherosclerosis	0.0636	0.0885	CbGbCtD
Zaleplon—CYP3A5—Lovastatin—atherosclerosis	0.0623	0.0866	CbGbCtD
Zaleplon—CYP3A5—Pravastatin—atherosclerosis	0.0623	0.0866	CbGbCtD
Zaleplon—CYP3A4—Ezetimibe—atherosclerosis	0.0267	0.0371	CbGbCtD
Zaleplon—CYP3A4—Rosuvastatin—atherosclerosis	0.0267	0.0371	CbGbCtD
Zaleplon—CYP3A4—Simvastatin—atherosclerosis	0.0248	0.0345	CbGbCtD
Zaleplon—CYP3A4—Lovastatin—atherosclerosis	0.0243	0.0338	CbGbCtD
Zaleplon—CYP3A4—Pravastatin—atherosclerosis	0.0243	0.0338	CbGbCtD
Zaleplon—TSPO—hindlimb—atherosclerosis	0.00159	0.188	CbGeAlD
Zaleplon—TSPO—appendage—atherosclerosis	0.00137	0.161	CbGeAlD
Zaleplon—TSPO—artery—atherosclerosis	0.000977	0.115	CbGeAlD
Zaleplon—TSPO—blood vessel—atherosclerosis	0.000761	0.0896	CbGeAlD
Zaleplon—Erectile dysfunction—Niacin—atherosclerosis	0.000656	0.00269	CcSEcCtD
Zaleplon—Dysuria—Pravastatin—atherosclerosis	0.000655	0.00269	CcSEcCtD
Zaleplon—Erectile dysfunction—Pravastatin—atherosclerosis	0.000645	0.00265	CcSEcCtD
Zaleplon—Oedema peripheral—Ezetimibe—atherosclerosis	0.000641	0.00263	CcSEcCtD
Zaleplon—Photosensitivity reaction—Pravastatin—atherosclerosis	0.00064	0.00262	CcSEcCtD
Zaleplon—Weight increased—Pravastatin—atherosclerosis	0.000638	0.00262	CcSEcCtD
Zaleplon—Weight decreased—Pravastatin—atherosclerosis	0.000634	0.0026	CcSEcCtD
Zaleplon—Depression—Pravastatin—atherosclerosis	0.000623	0.00256	CcSEcCtD
Zaleplon—Angioedema—Rosuvastatin—atherosclerosis	0.000623	0.00255	CcSEcCtD
Zaleplon—Stomatitis—Niacin—atherosclerosis	0.000619	0.00254	CcSEcCtD
Zaleplon—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000612	0.00251	CcSEcCtD
Zaleplon—Sweating—Niacin—atherosclerosis	0.000608	0.0025	CcSEcCtD
Zaleplon—Chills—Lovastatin—atherosclerosis	0.000595	0.00244	CcSEcCtD
Zaleplon—Immune system disorder—Ezetimibe—atherosclerosis	0.000588	0.00241	CcSEcCtD
Zaleplon—Alopecia—Lovastatin—atherosclerosis	0.000586	0.00241	CcSEcCtD
Zaleplon—Arthralgia—Rosuvastatin—atherosclerosis	0.00058	0.00238	CcSEcCtD
Zaleplon—Myalgia—Rosuvastatin—atherosclerosis	0.00058	0.00238	CcSEcCtD
Zaleplon—Alopecia—Ezetimibe—atherosclerosis	0.000575	0.00236	CcSEcCtD
Zaleplon—Mental disorder—Ezetimibe—atherosclerosis	0.00057	0.00234	CcSEcCtD
Zaleplon—Flatulence—Lovastatin—atherosclerosis	0.000569	0.00233	CcSEcCtD
Zaleplon—Hypoaesthesia—Niacin—atherosclerosis	0.000567	0.00233	CcSEcCtD
Zaleplon—Malnutrition—Ezetimibe—atherosclerosis	0.000566	0.00232	CcSEcCtD
Zaleplon—Dysgeusia—Lovastatin—atherosclerosis	0.000565	0.00232	CcSEcCtD
Zaleplon—Oedema peripheral—Niacin—atherosclerosis	0.000561	0.0023	CcSEcCtD
Zaleplon—Confusional state—Rosuvastatin—atherosclerosis	0.000561	0.0023	CcSEcCtD
Zaleplon—Back pain—Lovastatin—atherosclerosis	0.000559	0.00229	CcSEcCtD
Zaleplon—Hypoaesthesia—Pravastatin—atherosclerosis	0.000558	0.00229	CcSEcCtD
Zaleplon—Flatulence—Ezetimibe—atherosclerosis	0.000558	0.00229	CcSEcCtD
Zaleplon—Chills—Simvastatin—atherosclerosis	0.000557	0.00228	CcSEcCtD
Zaleplon—Visual impairment—Niacin—atherosclerosis	0.000549	0.00225	CcSEcCtD
Zaleplon—Alopecia—Simvastatin—atherosclerosis	0.000548	0.00225	CcSEcCtD
Zaleplon—Back pain—Ezetimibe—atherosclerosis	0.000548	0.00225	CcSEcCtD
Zaleplon—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000545	0.00224	CcSEcCtD
Zaleplon—Mental disorder—Simvastatin—atherosclerosis	0.000544	0.00223	CcSEcCtD
Zaleplon—Tremor—Lovastatin—atherosclerosis	0.000541	0.00222	CcSEcCtD
Zaleplon—Visual impairment—Pravastatin—atherosclerosis	0.000541	0.00222	CcSEcCtD
Zaleplon—Ill-defined disorder—Lovastatin—atherosclerosis	0.000536	0.0022	CcSEcCtD
Zaleplon—Eye disorder—Niacin—atherosclerosis	0.000532	0.00218	CcSEcCtD
Zaleplon—Flatulence—Simvastatin—atherosclerosis	0.000532	0.00218	CcSEcCtD
Zaleplon—Tinnitus—Niacin—atherosclerosis	0.000531	0.00218	CcSEcCtD
Zaleplon—Dysgeusia—Simvastatin—atherosclerosis	0.000529	0.00217	CcSEcCtD
Zaleplon—Angioedema—Lovastatin—atherosclerosis	0.000528	0.00216	CcSEcCtD
Zaleplon—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000525	0.00216	CcSEcCtD
Zaleplon—Anaemia—Ezetimibe—atherosclerosis	0.000523	0.00215	CcSEcCtD
Zaleplon—Tinnitus—Pravastatin—atherosclerosis	0.000523	0.00215	CcSEcCtD
Zaleplon—Malaise—Lovastatin—atherosclerosis	0.000521	0.00214	CcSEcCtD
Zaleplon—Vertigo—Lovastatin—atherosclerosis	0.000519	0.00213	CcSEcCtD
Zaleplon—Angioedema—Ezetimibe—atherosclerosis	0.000518	0.00212	CcSEcCtD
Zaleplon—Chills—Niacin—atherosclerosis	0.000511	0.0021	CcSEcCtD
Zaleplon—Malaise—Ezetimibe—atherosclerosis	0.000511	0.0021	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000507	0.00208	CcSEcCtD
Zaleplon—Tremor—Simvastatin—atherosclerosis	0.000506	0.00208	CcSEcCtD
Zaleplon—Alopecia—Niacin—atherosclerosis	0.000503	0.00207	CcSEcCtD
Zaleplon—Chills—Pravastatin—atherosclerosis	0.000503	0.00207	CcSEcCtD
Zaleplon—Insomnia—Rosuvastatin—atherosclerosis	0.000503	0.00206	CcSEcCtD
Zaleplon—Ill-defined disorder—Simvastatin—atherosclerosis	0.000501	0.00206	CcSEcCtD
Zaleplon—Palpitations—Ezetimibe—atherosclerosis	0.0005	0.00205	CcSEcCtD
Zaleplon—Paraesthesia—Rosuvastatin—atherosclerosis	0.000499	0.00205	CcSEcCtD
Zaleplon—Anaemia—Simvastatin—atherosclerosis	0.000499	0.00205	CcSEcCtD
Zaleplon—Malnutrition—Niacin—atherosclerosis	0.000496	0.00203	CcSEcCtD
Zaleplon—Alopecia—Pravastatin—atherosclerosis	0.000496	0.00203	CcSEcCtD
Zaleplon—Angioedema—Simvastatin—atherosclerosis	0.000494	0.00203	CcSEcCtD
Zaleplon—Arthralgia—Lovastatin—atherosclerosis	0.000492	0.00202	CcSEcCtD
Zaleplon—Chest pain—Lovastatin—atherosclerosis	0.000492	0.00202	CcSEcCtD
Zaleplon—Myalgia—Lovastatin—atherosclerosis	0.000492	0.00202	CcSEcCtD
Zaleplon—Anxiety—Lovastatin—atherosclerosis	0.00049	0.00201	CcSEcCtD
Zaleplon—Dyspepsia—Rosuvastatin—atherosclerosis	0.000489	0.00201	CcSEcCtD
Zaleplon—Hypertension—Ezetimibe—atherosclerosis	0.000489	0.00201	CcSEcCtD
Zaleplon—Flatulence—Niacin—atherosclerosis	0.000489	0.00201	CcSEcCtD
Zaleplon—Malaise—Simvastatin—atherosclerosis	0.000487	0.002	CcSEcCtD
Zaleplon—Tension—Niacin—atherosclerosis	0.000487	0.002	CcSEcCtD
Zaleplon—Discomfort—Lovastatin—atherosclerosis	0.000486	0.00199	CcSEcCtD
Zaleplon—Vertigo—Simvastatin—atherosclerosis	0.000485	0.00199	CcSEcCtD
Zaleplon—Myalgia—Ezetimibe—atherosclerosis	0.000482	0.00198	CcSEcCtD
Zaleplon—Chest pain—Ezetimibe—atherosclerosis	0.000482	0.00198	CcSEcCtD
Zaleplon—Arthralgia—Ezetimibe—atherosclerosis	0.000482	0.00198	CcSEcCtD
Zaleplon—Nervousness—Niacin—atherosclerosis	0.000482	0.00198	CcSEcCtD
Zaleplon—Flatulence—Pravastatin—atherosclerosis	0.000481	0.00197	CcSEcCtD
Zaleplon—Dry mouth—Lovastatin—atherosclerosis	0.000481	0.00197	CcSEcCtD
Zaleplon—Tension—Pravastatin—atherosclerosis	0.000479	0.00197	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000479	0.00196	CcSEcCtD
Zaleplon—Dysgeusia—Pravastatin—atherosclerosis	0.000478	0.00196	CcSEcCtD
Zaleplon—Discomfort—Ezetimibe—atherosclerosis	0.000476	0.00195	CcSEcCtD
Zaleplon—Pain—Rosuvastatin—atherosclerosis	0.000476	0.00195	CcSEcCtD
Zaleplon—Constipation—Rosuvastatin—atherosclerosis	0.000476	0.00195	CcSEcCtD
Zaleplon—Confusional state—Lovastatin—atherosclerosis	0.000475	0.00195	CcSEcCtD
Zaleplon—Nervousness—Pravastatin—atherosclerosis	0.000474	0.00195	CcSEcCtD
Zaleplon—Dry mouth—Ezetimibe—atherosclerosis	0.000472	0.00193	CcSEcCtD
Zaleplon—Anaphylactic shock—Lovastatin—atherosclerosis	0.000471	0.00193	CcSEcCtD
Zaleplon—Confusional state—Ezetimibe—atherosclerosis	0.000466	0.00191	CcSEcCtD
Zaleplon—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000462	0.0019	CcSEcCtD
Zaleplon—Myalgia—Simvastatin—atherosclerosis	0.00046	0.00189	CcSEcCtD
Zaleplon—Arthralgia—Simvastatin—atherosclerosis	0.00046	0.00189	CcSEcCtD
Zaleplon—Chest pain—Simvastatin—atherosclerosis	0.00046	0.00189	CcSEcCtD
Zaleplon—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000458	0.00188	CcSEcCtD
Zaleplon—Anxiety—Simvastatin—atherosclerosis	0.000458	0.00188	CcSEcCtD
Zaleplon—Tremor—Pravastatin—atherosclerosis	0.000457	0.00188	CcSEcCtD
Zaleplon—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000455	0.00187	CcSEcCtD
Zaleplon—Discomfort—Simvastatin—atherosclerosis	0.000454	0.00186	CcSEcCtD
Zaleplon—Nervous system disorder—Ezetimibe—atherosclerosis	0.000453	0.00186	CcSEcCtD
Zaleplon—Angioedema—Niacin—atherosclerosis	0.000453	0.00186	CcSEcCtD
Zaleplon—Ill-defined disorder—Pravastatin—atherosclerosis	0.000453	0.00186	CcSEcCtD
Zaleplon—Anaemia—Pravastatin—atherosclerosis	0.000451	0.00185	CcSEcCtD
Zaleplon—Anorexia—Lovastatin—atherosclerosis	0.000449	0.00184	CcSEcCtD
Zaleplon—Skin disorder—Ezetimibe—atherosclerosis	0.000449	0.00184	CcSEcCtD
Zaleplon—Angioedema—Pravastatin—atherosclerosis	0.000446	0.00183	CcSEcCtD
Zaleplon—Vertigo—Niacin—atherosclerosis	0.000446	0.00183	CcSEcCtD
Zaleplon—Syncope—Niacin—atherosclerosis	0.000445	0.00182	CcSEcCtD
Zaleplon—Confusional state—Simvastatin—atherosclerosis	0.000444	0.00182	CcSEcCtD
Zaleplon—Urticaria—Rosuvastatin—atherosclerosis	0.000442	0.00181	CcSEcCtD
Zaleplon—Oedema—Simvastatin—atherosclerosis	0.000441	0.00181	CcSEcCtD
Zaleplon—Anaphylactic shock—Simvastatin—atherosclerosis	0.000441	0.00181	CcSEcCtD
Zaleplon—Malaise—Pravastatin—atherosclerosis	0.00044	0.00181	CcSEcCtD
Zaleplon—Abdominal pain—Rosuvastatin—atherosclerosis	0.00044	0.0018	CcSEcCtD
Zaleplon—Vertigo—Pravastatin—atherosclerosis	0.000439	0.0018	CcSEcCtD
Zaleplon—Palpitations—Niacin—atherosclerosis	0.000438	0.0018	CcSEcCtD
Zaleplon—Loss of consciousness—Niacin—atherosclerosis	0.000436	0.00179	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000429	0.00176	CcSEcCtD
Zaleplon—Insomnia—Lovastatin—atherosclerosis	0.000426	0.00175	CcSEcCtD
Zaleplon—Paraesthesia—Lovastatin—atherosclerosis	0.000423	0.00174	CcSEcCtD
Zaleplon—Myalgia—Niacin—atherosclerosis	0.000422	0.00173	CcSEcCtD
Zaleplon—Arthralgia—Niacin—atherosclerosis	0.000422	0.00173	CcSEcCtD
Zaleplon—Hypertension—Pravastatin—atherosclerosis	0.000422	0.00173	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000421	0.00173	CcSEcCtD
Zaleplon—Anorexia—Simvastatin—atherosclerosis	0.00042	0.00172	CcSEcCtD
Zaleplon—Dyspnoea—Lovastatin—atherosclerosis	0.00042	0.00172	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000419	0.00172	CcSEcCtD
Zaleplon—Insomnia—Ezetimibe—atherosclerosis	0.000418	0.00172	CcSEcCtD
Zaleplon—Arthralgia—Pravastatin—atherosclerosis	0.000416	0.00171	CcSEcCtD
Zaleplon—Chest pain—Pravastatin—atherosclerosis	0.000416	0.00171	CcSEcCtD
Zaleplon—Myalgia—Pravastatin—atherosclerosis	0.000416	0.00171	CcSEcCtD
Zaleplon—Paraesthesia—Ezetimibe—atherosclerosis	0.000415	0.0017	CcSEcCtD
Zaleplon—Dyspepsia—Lovastatin—atherosclerosis	0.000415	0.0017	CcSEcCtD
Zaleplon—Anxiety—Pravastatin—atherosclerosis	0.000414	0.0017	CcSEcCtD
Zaleplon—Dry mouth—Niacin—atherosclerosis	0.000413	0.00169	CcSEcCtD
Zaleplon—Dyspnoea—Ezetimibe—atherosclerosis	0.000412	0.00169	CcSEcCtD
Zaleplon—Discomfort—Pravastatin—atherosclerosis	0.000411	0.00169	CcSEcCtD
Zaleplon—Decreased appetite—Lovastatin—atherosclerosis	0.00041	0.00168	CcSEcCtD
Zaleplon—Dyspepsia—Ezetimibe—atherosclerosis	0.000407	0.00167	CcSEcCtD
Zaleplon—Oedema—Niacin—atherosclerosis	0.000405	0.00166	CcSEcCtD
Zaleplon—Anaphylactic shock—Niacin—atherosclerosis	0.000405	0.00166	CcSEcCtD
Zaleplon—Constipation—Lovastatin—atherosclerosis	0.000403	0.00165	CcSEcCtD
Zaleplon—Pain—Lovastatin—atherosclerosis	0.000403	0.00165	CcSEcCtD
Zaleplon—Confusional state—Pravastatin—atherosclerosis	0.000402	0.00165	CcSEcCtD
Zaleplon—Decreased appetite—Ezetimibe—atherosclerosis	0.000402	0.00165	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000402	0.00165	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000399	0.00164	CcSEcCtD
Zaleplon—Asthenia—Rosuvastatin—atherosclerosis	0.000399	0.00164	CcSEcCtD
Zaleplon—Insomnia—Simvastatin—atherosclerosis	0.000399	0.00164	CcSEcCtD
Zaleplon—Oedema—Pravastatin—atherosclerosis	0.000399	0.00164	CcSEcCtD
Zaleplon—Anaphylactic shock—Pravastatin—atherosclerosis	0.000399	0.00164	CcSEcCtD
Zaleplon—Shock—Niacin—atherosclerosis	0.000398	0.00163	CcSEcCtD
Zaleplon—Paraesthesia—Simvastatin—atherosclerosis	0.000396	0.00162	CcSEcCtD
Zaleplon—Constipation—Ezetimibe—atherosclerosis	0.000395	0.00162	CcSEcCtD
Zaleplon—Pain—Ezetimibe—atherosclerosis	0.000395	0.00162	CcSEcCtD
Zaleplon—Tachycardia—Niacin—atherosclerosis	0.000395	0.00162	CcSEcCtD
Zaleplon—Pruritus—Rosuvastatin—atherosclerosis	0.000393	0.00161	CcSEcCtD
Zaleplon—Skin disorder—Niacin—atherosclerosis	0.000393	0.00161	CcSEcCtD
Zaleplon—Dyspnoea—Simvastatin—atherosclerosis	0.000393	0.00161	CcSEcCtD
Zaleplon—Hyperhidrosis—Niacin—atherosclerosis	0.000391	0.00161	CcSEcCtD
Zaleplon—TSPO—connective tissue—atherosclerosis	0.00039	0.0459	CbGeAlD
Zaleplon—Feeling abnormal—Lovastatin—atherosclerosis	0.000388	0.00159	CcSEcCtD
Zaleplon—Dyspepsia—Simvastatin—atherosclerosis	0.000388	0.00159	CcSEcCtD
Zaleplon—Anorexia—Niacin—atherosclerosis	0.000386	0.00158	CcSEcCtD
Zaleplon—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000385	0.00158	CcSEcCtD
Zaleplon—Hyperhidrosis—Pravastatin—atherosclerosis	0.000385	0.00158	CcSEcCtD
Zaleplon—Decreased appetite—Simvastatin—atherosclerosis	0.000383	0.00157	CcSEcCtD
Zaleplon—Feeling abnormal—Ezetimibe—atherosclerosis	0.000381	0.00156	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000381	0.00156	CcSEcCtD
Zaleplon—Anorexia—Pravastatin—atherosclerosis	0.00038	0.00156	CcSEcCtD
Zaleplon—Hypotension—Niacin—atherosclerosis	0.000378	0.00155	CcSEcCtD
Zaleplon—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000378	0.00155	CcSEcCtD
Zaleplon—Pain—Simvastatin—atherosclerosis	0.000377	0.00155	CcSEcCtD
Zaleplon—Constipation—Simvastatin—atherosclerosis	0.000377	0.00155	CcSEcCtD
Zaleplon—Urticaria—Lovastatin—atherosclerosis	0.000374	0.00154	CcSEcCtD
Zaleplon—Body temperature increased—Lovastatin—atherosclerosis	0.000373	0.00153	CcSEcCtD
Zaleplon—Abdominal pain—Lovastatin—atherosclerosis	0.000373	0.00153	CcSEcCtD
Zaleplon—CYP3A7—liver—atherosclerosis	0.000369	0.0435	CbGeAlD
Zaleplon—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000369	0.00151	CcSEcCtD
Zaleplon—Dizziness—Rosuvastatin—atherosclerosis	0.000368	0.00151	CcSEcCtD
Zaleplon—Urticaria—Ezetimibe—atherosclerosis	0.000367	0.00151	CcSEcCtD
Zaleplon—Insomnia—Niacin—atherosclerosis	0.000366	0.0015	CcSEcCtD
Zaleplon—Abdominal pain—Ezetimibe—atherosclerosis	0.000365	0.0015	CcSEcCtD
Zaleplon—Body temperature increased—Ezetimibe—atherosclerosis	0.000365	0.0015	CcSEcCtD
Zaleplon—Paraesthesia—Niacin—atherosclerosis	0.000363	0.00149	CcSEcCtD
Zaleplon—Feeling abnormal—Simvastatin—atherosclerosis	0.000363	0.00149	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000363	0.00149	CcSEcCtD
Zaleplon—Dyspnoea—Niacin—atherosclerosis	0.000361	0.00148	CcSEcCtD
Zaleplon—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00036	0.00148	CcSEcCtD
Zaleplon—Insomnia—Pravastatin—atherosclerosis	0.00036	0.00148	CcSEcCtD
Zaleplon—Somnolence—Niacin—atherosclerosis	0.00036	0.00148	CcSEcCtD
Zaleplon—Paraesthesia—Pravastatin—atherosclerosis	0.000358	0.00147	CcSEcCtD
Zaleplon—Dyspepsia—Niacin—atherosclerosis	0.000356	0.00146	CcSEcCtD
Zaleplon—Dyspnoea—Pravastatin—atherosclerosis	0.000355	0.00146	CcSEcCtD
Zaleplon—GABRB3—connective tissue—atherosclerosis	0.000354	0.0417	CbGeAlD
Zaleplon—Decreased appetite—Niacin—atherosclerosis	0.000352	0.00144	CcSEcCtD
Zaleplon—Dyspepsia—Pravastatin—atherosclerosis	0.000351	0.00144	CcSEcCtD
Zaleplon—Rash—Rosuvastatin—atherosclerosis	0.000351	0.00144	CcSEcCtD
Zaleplon—AOX1—adipose tissue—atherosclerosis	0.00035	0.0412	CbGeAlD
Zaleplon—Dermatitis—Rosuvastatin—atherosclerosis	0.00035	0.00144	CcSEcCtD
Zaleplon—Urticaria—Simvastatin—atherosclerosis	0.00035	0.00144	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Niacin—atherosclerosis	0.000349	0.00143	CcSEcCtD
Zaleplon—Body temperature increased—Simvastatin—atherosclerosis	0.000348	0.00143	CcSEcCtD
Zaleplon—Abdominal pain—Simvastatin—atherosclerosis	0.000348	0.00143	CcSEcCtD
Zaleplon—Headache—Rosuvastatin—atherosclerosis	0.000348	0.00143	CcSEcCtD
Zaleplon—Decreased appetite—Pravastatin—atherosclerosis	0.000346	0.00142	CcSEcCtD
Zaleplon—Pain—Niacin—atherosclerosis	0.000346	0.00142	CcSEcCtD
Zaleplon—Pain—Pravastatin—atherosclerosis	0.000341	0.0014	CcSEcCtD
Zaleplon—Constipation—Pravastatin—atherosclerosis	0.000341	0.0014	CcSEcCtD
Zaleplon—TSPO—cardiovascular system—atherosclerosis	0.000339	0.04	CbGeAlD
Zaleplon—Asthenia—Lovastatin—atherosclerosis	0.000338	0.00139	CcSEcCtD
Zaleplon—Pruritus—Lovastatin—atherosclerosis	0.000333	0.00137	CcSEcCtD
Zaleplon—Asthenia—Ezetimibe—atherosclerosis	0.000332	0.00136	CcSEcCtD
Zaleplon—Gastrointestinal pain—Niacin—atherosclerosis	0.000331	0.00136	CcSEcCtD
Zaleplon—Nausea—Rosuvastatin—atherosclerosis	0.00033	0.00136	CcSEcCtD
Zaleplon—Feeling abnormal—Pravastatin—atherosclerosis	0.000328	0.00135	CcSEcCtD
Zaleplon—Pruritus—Ezetimibe—atherosclerosis	0.000327	0.00134	CcSEcCtD
Zaleplon—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000326	0.00134	CcSEcCtD
Zaleplon—GABRA2—adipose tissue—atherosclerosis	0.000323	0.0381	CbGeAlD
Zaleplon—Urticaria—Niacin—atherosclerosis	0.000322	0.00132	CcSEcCtD
Zaleplon—Body temperature increased—Niacin—atherosclerosis	0.00032	0.00131	CcSEcCtD
Zaleplon—Abdominal pain—Niacin—atherosclerosis	0.00032	0.00131	CcSEcCtD
Zaleplon—Urticaria—Pravastatin—atherosclerosis	0.000317	0.0013	CcSEcCtD
Zaleplon—Asthenia—Simvastatin—atherosclerosis	0.000316	0.0013	CcSEcCtD
Zaleplon—Abdominal pain—Pravastatin—atherosclerosis	0.000315	0.00129	CcSEcCtD
Zaleplon—Body temperature increased—Pravastatin—atherosclerosis	0.000315	0.00129	CcSEcCtD
Zaleplon—CYP3A7-CYP3A51P—liver—atherosclerosis	0.000314	0.037	CbGeAlD
Zaleplon—Pruritus—Simvastatin—atherosclerosis	0.000312	0.00128	CcSEcCtD
Zaleplon—Dizziness—Lovastatin—atherosclerosis	0.000312	0.00128	CcSEcCtD
Zaleplon—Dizziness—Ezetimibe—atherosclerosis	0.000306	0.00125	CcSEcCtD
Zaleplon—TSPO—adipose tissue—atherosclerosis	0.000299	0.0352	CbGeAlD
Zaleplon—Rash—Lovastatin—atherosclerosis	0.000297	0.00122	CcSEcCtD
Zaleplon—Dermatitis—Lovastatin—atherosclerosis	0.000297	0.00122	CcSEcCtD
Zaleplon—Headache—Lovastatin—atherosclerosis	0.000295	0.00121	CcSEcCtD
Zaleplon—Dizziness—Simvastatin—atherosclerosis	0.000291	0.0012	CcSEcCtD
Zaleplon—Rash—Ezetimibe—atherosclerosis	0.000291	0.0012	CcSEcCtD
Zaleplon—Dermatitis—Ezetimibe—atherosclerosis	0.000291	0.00119	CcSEcCtD
Zaleplon—Asthenia—Niacin—atherosclerosis	0.00029	0.00119	CcSEcCtD
Zaleplon—Headache—Ezetimibe—atherosclerosis	0.00029	0.00119	CcSEcCtD
Zaleplon—Pruritus—Niacin—atherosclerosis	0.000286	0.00117	CcSEcCtD
Zaleplon—Asthenia—Pravastatin—atherosclerosis	0.000286	0.00117	CcSEcCtD
Zaleplon—Pruritus—Pravastatin—atherosclerosis	0.000282	0.00116	CcSEcCtD
Zaleplon—Nausea—Lovastatin—atherosclerosis	0.00028	0.00115	CcSEcCtD
Zaleplon—Rash—Simvastatin—atherosclerosis	0.000278	0.00114	CcSEcCtD
Zaleplon—Dermatitis—Simvastatin—atherosclerosis	0.000278	0.00114	CcSEcCtD
Zaleplon—Headache—Simvastatin—atherosclerosis	0.000276	0.00113	CcSEcCtD
Zaleplon—Nausea—Ezetimibe—atherosclerosis	0.000275	0.00113	CcSEcCtD
Zaleplon—Dizziness—Niacin—atherosclerosis	0.000268	0.0011	CcSEcCtD
Zaleplon—Dizziness—Pravastatin—atherosclerosis	0.000264	0.00108	CcSEcCtD
Zaleplon—Nausea—Simvastatin—atherosclerosis	0.000262	0.00107	CcSEcCtD
Zaleplon—Rash—Niacin—atherosclerosis	0.000255	0.00105	CcSEcCtD
Zaleplon—Dermatitis—Niacin—atherosclerosis	0.000255	0.00105	CcSEcCtD
Zaleplon—Headache—Niacin—atherosclerosis	0.000254	0.00104	CcSEcCtD
Zaleplon—Rash—Pravastatin—atherosclerosis	0.000251	0.00103	CcSEcCtD
Zaleplon—Dermatitis—Pravastatin—atherosclerosis	0.000251	0.00103	CcSEcCtD
Zaleplon—Headache—Pravastatin—atherosclerosis	0.00025	0.00102	CcSEcCtD
Zaleplon—AOX1—liver—atherosclerosis	0.000246	0.0289	CbGeAlD
Zaleplon—Nausea—Niacin—atherosclerosis	0.00024	0.000986	CcSEcCtD
Zaleplon—Nausea—Pravastatin—atherosclerosis	0.000237	0.000971	CcSEcCtD
Zaleplon—TSPO—liver—atherosclerosis	0.00021	0.0247	CbGeAlD
Zaleplon—GABRB3—liver—atherosclerosis	0.000191	0.0224	CbGeAlD
Zaleplon—CYP3A5—adipose tissue—atherosclerosis	0.000185	0.0218	CbGeAlD
Zaleplon—CYP3A5—liver—atherosclerosis	0.00013	0.0153	CbGeAlD
Zaleplon—CYP3A4—liver—atherosclerosis	9.76e-05	0.0115	CbGeAlD
Zaleplon—AOX1—Disease—NAMPT—atherosclerosis	4.36e-05	0.00151	CbGpPWpGaD
Zaleplon—AOX1—Disease—APOC3—atherosclerosis	4.3e-05	0.00149	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—GSTM1—atherosclerosis	4.28e-05	0.00148	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—CETP—atherosclerosis	4.28e-05	0.00148	CbGpPWpGaD
Zaleplon—AOX1—Disease—LDLR—atherosclerosis	4.28e-05	0.00148	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—CETP—atherosclerosis	4.25e-05	0.00147	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—NFKB1—atherosclerosis	4.23e-05	0.00146	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—GSTM1—atherosclerosis	4.22e-05	0.00146	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PLA2G1B—atherosclerosis	4.21e-05	0.00146	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—LDLRAP1—atherosclerosis	4.2e-05	0.00145	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—CETP—atherosclerosis	4.17e-05	0.00144	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—PRKCG—atherosclerosis	4.17e-05	0.00144	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—MAPK8—atherosclerosis	4.16e-05	0.00144	CbGpPWpGaD
Zaleplon—AOX1—Disease—HSPA1B—atherosclerosis	4.13e-05	0.00143	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALOX5—atherosclerosis	4.07e-05	0.00141	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—PLAT—atherosclerosis	4.02e-05	0.00139	CbGpPWpGaD
Zaleplon—AOX1—Disease—NCF1—atherosclerosis	4e-05	0.00138	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PLTP—atherosclerosis	3.95e-05	0.00136	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	3.81e-05	0.00131	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—STAT3—atherosclerosis	3.8e-05	0.00131	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—PLAT—atherosclerosis	3.77e-05	0.0013	CbGpPWpGaD
Zaleplon—AOX1—Disease—CYBA—atherosclerosis	3.76e-05	0.0013	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—PLAT—atherosclerosis	3.75e-05	0.00129	CbGpPWpGaD
Zaleplon—AOX1—Disease—PARP1—atherosclerosis	3.68e-05	0.00127	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—PLAT—atherosclerosis	3.68e-05	0.00127	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	3.65e-05	0.00126	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—NAMPT—atherosclerosis	3.65e-05	0.00126	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—CETP—atherosclerosis	3.65e-05	0.00126	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—MAPK3—atherosclerosis	3.63e-05	0.00125	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—LIPC—atherosclerosis	3.63e-05	0.00125	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—APOC3—atherosclerosis	3.6e-05	0.00124	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—LDLR—atherosclerosis	3.58e-05	0.00124	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CETP—atherosclerosis	3.5e-05	0.00121	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ABCG8—atherosclerosis	3.42e-05	0.00118	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—LTA4H—atherosclerosis	3.42e-05	0.00118	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—PLG—atherosclerosis	3.42e-05	0.00118	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	3.41e-05	0.00118	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—SCARB1—atherosclerosis	3.35e-05	0.00116	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—PLAT—atherosclerosis	3.21e-05	0.00111	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—PLG—atherosclerosis	3.21e-05	0.00111	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—PLG—atherosclerosis	3.18e-05	0.0011	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—HMGCR—atherosclerosis	3.16e-05	0.00109	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.16e-05	0.00109	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—PLG—atherosclerosis	3.13e-05	0.00108	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	3.09e-05	0.00107	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—LDLRAP1—atherosclerosis	3.03e-05	0.00105	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—APOB—atherosclerosis	3.02e-05	0.00104	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.96e-05	0.00102	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.94e-05	0.00102	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.89e-05	0.000997	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PLTP—atherosclerosis	2.85e-05	0.000985	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—APOB—atherosclerosis	2.83e-05	0.000979	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ABCA1—atherosclerosis	2.82e-05	0.000974	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—APOB—atherosclerosis	2.81e-05	0.000973	CbGpPWpGaD
Zaleplon—AOX1—Disease—APOB—atherosclerosis	2.77e-05	0.000956	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—APOB—atherosclerosis	2.76e-05	0.000955	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—PLG—atherosclerosis	2.73e-05	0.000944	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ABCG1—atherosclerosis	2.7e-05	0.000934	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—TNF—atherosclerosis	2.65e-05	0.000915	CbGpPWpGaD
Zaleplon—AOX1—Disease—LPL—atherosclerosis	2.64e-05	0.000913	CbGpPWpGaD
Zaleplon—AOX1—Disease—PRKCG—atherosclerosis	2.57e-05	0.000887	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.55e-05	0.000881	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—FABP4—atherosclerosis	2.54e-05	0.000878	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—LCAT—atherosclerosis	2.54e-05	0.000878	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.52e-05	0.000871	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—APOA4—atherosclerosis	2.5e-05	0.000862	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCG8—atherosclerosis	2.47e-05	0.000854	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—LTA4H—atherosclerosis	2.47e-05	0.000854	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP7A1—atherosclerosis	2.45e-05	0.000847	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—AKT1—atherosclerosis	2.45e-05	0.000846	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—HMOX1—atherosclerosis	2.42e-05	0.000836	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—APOB—atherosclerosis	2.42e-05	0.000835	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.39e-05	0.000826	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.39e-05	0.000826	CbGpPWpGaD
Zaleplon—AOX1—Disease—MTHFR—atherosclerosis	2.38e-05	0.000822	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.37e-05	0.00082	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.33e-05	0.000805	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—APOB—atherosclerosis	2.32e-05	0.000801	CbGpPWpGaD
Zaleplon—AOX1—Disease—PDGFB—atherosclerosis	2.32e-05	0.0008	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP27A1—atherosclerosis	2.27e-05	0.000783	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTM1—atherosclerosis	2.25e-05	0.000779	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.24e-05	0.000775	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.23e-05	0.000769	CbGpPWpGaD
Zaleplon—AOX1—Disease—APOE—atherosclerosis	2.21e-05	0.000765	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—LPL—atherosclerosis	2.21e-05	0.000764	CbGpPWpGaD
Zaleplon—AOX1—Disease—CAV1—atherosclerosis	2.19e-05	0.000758	CbGpPWpGaD
Zaleplon—AOX1—Disease—APOA1—atherosclerosis	2.19e-05	0.000756	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.19e-05	0.000756	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GPX1—atherosclerosis	2.16e-05	0.000746	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALOX5AP—atherosclerosis	2.15e-05	0.000742	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—APOA2—atherosclerosis	2.15e-05	0.000742	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALOX15—atherosclerosis	2.15e-05	0.000742	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PLA2G2A—atherosclerosis	2.15e-05	0.000742	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL6—atherosclerosis	2.14e-05	0.000739	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ABCG5—atherosclerosis	2.12e-05	0.000733	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CD36—atherosclerosis	2.1e-05	0.000726	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOS2—atherosclerosis	2.06e-05	0.000713	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—LPA—atherosclerosis	2.05e-05	0.000708	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.04e-05	0.000704	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—MTHFR—atherosclerosis	1.99e-05	0.000688	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	1.99e-05	0.000687	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—BGN—atherosclerosis	1.98e-05	0.000686	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—APOA5—atherosclerosis	1.96e-05	0.000679	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	1.96e-05	0.000678	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCG1—atherosclerosis	1.95e-05	0.000675	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PPARA—atherosclerosis	1.95e-05	0.000675	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.91e-05	0.00066	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—ALB—atherosclerosis	1.89e-05	0.000655	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—AGT—atherosclerosis	1.89e-05	0.000654	CbGpPWpGaD
Zaleplon—AOX1—Disease—INS—atherosclerosis	1.89e-05	0.000654	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PLA2G1B—atherosclerosis	1.89e-05	0.000653	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—APOE—atherosclerosis	1.85e-05	0.000641	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—LCAT—atherosclerosis	1.84e-05	0.000635	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—FABP4—atherosclerosis	1.84e-05	0.000635	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CAV1—atherosclerosis	1.84e-05	0.000635	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—APOA1—atherosclerosis	1.83e-05	0.000633	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALOX5—atherosclerosis	1.83e-05	0.000631	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—APOA4—atherosclerosis	1.8e-05	0.000623	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—ALB—atherosclerosis	1.78e-05	0.000614	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP7A1—atherosclerosis	1.77e-05	0.000612	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—ALB—atherosclerosis	1.76e-05	0.00061	CbGpPWpGaD
Zaleplon—AOX1—Disease—SERPINE1—atherosclerosis	1.74e-05	0.0006	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ALB—atherosclerosis	1.73e-05	0.000599	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CG—atherosclerosis	1.67e-05	0.000578	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOS3—atherosclerosis	1.66e-05	0.000573	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NAMPT—atherosclerosis	1.64e-05	0.000566	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP27A1—atherosclerosis	1.64e-05	0.000566	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—LIPC—atherosclerosis	1.63e-05	0.000563	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—APOC3—atherosclerosis	1.62e-05	0.000559	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PPARG—atherosclerosis	1.62e-05	0.000558	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—LDLR—atherosclerosis	1.61e-05	0.000556	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—INS—atherosclerosis	1.58e-05	0.000547	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CETP—atherosclerosis	1.57e-05	0.000543	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—APOA2—atherosclerosis	1.55e-05	0.000537	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PLA2G2A—atherosclerosis	1.55e-05	0.000537	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALOX5AP—atherosclerosis	1.55e-05	0.000537	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALOX15—atherosclerosis	1.55e-05	0.000537	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCG5—atherosclerosis	1.53e-05	0.00053	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTGS2—atherosclerosis	1.52e-05	0.000524	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.51e-05	0.000523	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SCARB1—atherosclerosis	1.5e-05	0.00052	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—LPA—atherosclerosis	1.48e-05	0.000512	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALB—atherosclerosis	1.45e-05	0.000502	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—BGN—atherosclerosis	1.43e-05	0.000496	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HMGCR—atherosclerosis	1.42e-05	0.000491	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—APOA5—atherosclerosis	1.42e-05	0.000491	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.41e-05	0.000487	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—NOS3—atherosclerosis	1.39e-05	0.00048	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PLA2G1B—atherosclerosis	1.37e-05	0.000472	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PLTP—atherosclerosis	1.33e-05	0.000458	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALOX5—atherosclerosis	1.32e-05	0.000456	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTGS2—atherosclerosis	1.27e-05	0.000439	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ABCA1—atherosclerosis	1.27e-05	0.000437	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NAMPT—atherosclerosis	1.18e-05	0.000409	CbGpPWpGaD
Zaleplon—AOX1—Disease—STAT3—atherosclerosis	1.18e-05	0.000409	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—LIPC—atherosclerosis	1.18e-05	0.000407	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—APOC3—atherosclerosis	1.17e-05	0.000404	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—LDLR—atherosclerosis	1.16e-05	0.000402	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.15e-05	0.000397	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.15e-05	0.000397	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CETP—atherosclerosis	1.14e-05	0.000392	CbGpPWpGaD
Zaleplon—AOX1—Disease—MAPK3—atherosclerosis	1.13e-05	0.000391	CbGpPWpGaD
Zaleplon—AOX1—Disease—TGFB1—atherosclerosis	1.1e-05	0.000379	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SCARB1—atherosclerosis	1.09e-05	0.000376	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HMOX1—atherosclerosis	1.09e-05	0.000375	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—APOB—atherosclerosis	1.04e-05	0.00036	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.03e-05	0.000355	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTM1—atherosclerosis	1.01e-05	0.00035	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—LPL—atherosclerosis	9.94e-06	0.000343	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GPX1—atherosclerosis	9.69e-06	0.000335	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CD36—atherosclerosis	9.44e-06	0.000326	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCA1—atherosclerosis	9.15e-06	0.000316	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCG1—atherosclerosis	9.09e-06	0.000314	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—MTHFR—atherosclerosis	8.95e-06	0.000309	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPARA—atherosclerosis	8.78e-06	0.000303	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—FABP4—atherosclerosis	8.54e-06	0.000295	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LCAT—atherosclerosis	8.54e-06	0.000295	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AGT—atherosclerosis	8.5e-06	0.000294	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—APOA4—atherosclerosis	8.39e-06	0.00029	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—APOE—atherosclerosis	8.33e-06	0.000288	CbGpPWpGaD
Zaleplon—AOX1—Disease—IL6—atherosclerosis	8.27e-06	0.000286	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CAV1—atherosclerosis	8.25e-06	0.000285	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP7A1—atherosclerosis	8.24e-06	0.000285	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—APOA1—atherosclerosis	8.23e-06	0.000284	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HMOX1—atherosclerosis	7.85e-06	0.000271	CbGpPWpGaD
Zaleplon—AOX1—Disease—AKT1—atherosclerosis	7.63e-06	0.000263	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP27A1—atherosclerosis	7.62e-06	0.000263	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—APOB—atherosclerosis	7.52e-06	0.00026	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CG—atherosclerosis	7.52e-06	0.00026	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTM1—atherosclerosis	7.32e-06	0.000253	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPARG—atherosclerosis	7.25e-06	0.000251	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—APOA2—atherosclerosis	7.22e-06	0.000249	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	7.22e-06	0.000249	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALOX15—atherosclerosis	7.22e-06	0.000249	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	7.22e-06	0.000249	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—LPL—atherosclerosis	7.18e-06	0.000248	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCG5—atherosclerosis	7.13e-06	0.000246	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—INS—atherosclerosis	7.11e-06	0.000246	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GPX1—atherosclerosis	7.01e-06	0.000242	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LPA—atherosclerosis	6.89e-06	0.000238	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CD36—atherosclerosis	6.82e-06	0.000236	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—BGN—atherosclerosis	6.67e-06	0.00023	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—APOA5—atherosclerosis	6.6e-06	0.000228	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALB—atherosclerosis	6.52e-06	0.000225	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—MTHFR—atherosclerosis	6.47e-06	0.000223	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—AKT1—atherosclerosis	6.39e-06	0.000221	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	6.36e-06	0.00022	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPARA—atherosclerosis	6.34e-06	0.000219	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NOS3—atherosclerosis	6.24e-06	0.000216	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AGT—atherosclerosis	6.14e-06	0.000212	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALOX5—atherosclerosis	6.14e-06	0.000212	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—APOE—atherosclerosis	6.02e-06	0.000208	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CAV1—atherosclerosis	5.96e-06	0.000206	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—APOA1—atherosclerosis	5.95e-06	0.000206	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTGS2—atherosclerosis	5.71e-06	0.000197	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.51e-06	0.00019	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LIPC—atherosclerosis	5.47e-06	0.000189	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—APOC3—atherosclerosis	5.44e-06	0.000188	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CG—atherosclerosis	5.43e-06	0.000188	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LDLR—atherosclerosis	5.4e-06	0.000187	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CETP—atherosclerosis	5.28e-06	0.000182	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPARG—atherosclerosis	5.24e-06	0.000181	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—INS—atherosclerosis	5.14e-06	0.000178	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SCARB1—atherosclerosis	5.06e-06	0.000175	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.77e-06	0.000165	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALB—atherosclerosis	4.72e-06	0.000163	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NOS3—atherosclerosis	4.51e-06	0.000156	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.26e-06	0.000147	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTGS2—atherosclerosis	4.13e-06	0.000143	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.65e-06	0.000126	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—APOB—atherosclerosis	3.5e-06	0.000121	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.4e-06	0.000118	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LPL—atherosclerosis	3.34e-06	0.000115	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GPX1—atherosclerosis	3.26e-06	0.000113	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CD36—atherosclerosis	3.17e-06	0.00011	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.01e-06	0.000104	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPARA—atherosclerosis	2.95e-06	0.000102	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AKT1—atherosclerosis	2.87e-06	9.91e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AGT—atherosclerosis	2.86e-06	9.87e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—APOE—atherosclerosis	2.8e-06	9.67e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CAV1—atherosclerosis	2.77e-06	9.58e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—APOA1—atherosclerosis	2.77e-06	9.56e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.53e-06	8.73e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPARG—atherosclerosis	2.44e-06	8.42e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—INS—atherosclerosis	2.39e-06	8.26e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALB—atherosclerosis	2.19e-06	7.57e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NOS3—atherosclerosis	2.1e-06	7.24e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AKT1—atherosclerosis	2.07e-06	7.16e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.92e-06	6.63e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AKT1—atherosclerosis	9.64e-07	3.33e-05	CbGpPWpGaD
